Genes Image Molecules link lower weight babies and chronic diseases July 3, 2026 BIO5 members Fernando Martinez, Anthony Bosco and Tara Carr contributed to research identifying molecules linked to lower birth weight and a higher risk of chronic diseases later in life, offering new insights into early-life health. Read more in U of A News Image New Study Discovers More Than 100 Genetic Links to Schizophrenia March 27, 2026 BIO5 member Ayman Fanous led the largest genetic study of schizophrenia in people of African ancestry, identifying more than 100 new genome regions linked to the condition and advancing understanding across populations. Read more in College of Medicine - Phoenix Image Tech Tuesday: Engineered stem cells offer treatment strategy for Type 1 diabetes and more Feb. 24, 2026 BIO5 member Deepta Bhattacharya is part of a University of Arizona research team developing gene-edited stem cells designed to avoid immune rejection, a breakthrough that could enable cell therapies for Type 1 diabetes without lifelong anti-rejection drugs. Read more in Tech Launch Arizona
Image Molecules link lower weight babies and chronic diseases July 3, 2026 BIO5 members Fernando Martinez, Anthony Bosco and Tara Carr contributed to research identifying molecules linked to lower birth weight and a higher risk of chronic diseases later in life, offering new insights into early-life health. Read more in U of A News
Image New Study Discovers More Than 100 Genetic Links to Schizophrenia March 27, 2026 BIO5 member Ayman Fanous led the largest genetic study of schizophrenia in people of African ancestry, identifying more than 100 new genome regions linked to the condition and advancing understanding across populations. Read more in College of Medicine - Phoenix
Image Tech Tuesday: Engineered stem cells offer treatment strategy for Type 1 diabetes and more Feb. 24, 2026 BIO5 member Deepta Bhattacharya is part of a University of Arizona research team developing gene-edited stem cells designed to avoid immune rejection, a breakthrough that could enable cell therapies for Type 1 diabetes without lifelong anti-rejection drugs. Read more in Tech Launch Arizona